The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Dynamic Functional Relay between Insulin Receptor Substrate 1 and 2 in Hepatic Insulin Signaling during Fasting and Feeding
Open accessAbstract
Insulin receptor substrate (Irs) mediates metabolic actions of insulin. Here, we show that hepatic Irs1 and Irs2 function in a distinct manner in the regulation of glucose homeostasis. The PI3K activity associated with Irs2 began to increase during fasting, reached its peak immediately after refeeding, and decreased rapidly thereafter. By contrast, the PI3K activity associated with Irs1 began to increase a few hours after refeeding and reached its peak thereafter. The data indicate that Irs2 mainly functions during fasting and immediately after refeeding, and Irs1 functions primarily after refeeding. In fact, liver-specific Irs1-knockout mice failed to exhibit insulin resistance during fasting, but showed insulin resistance after refeeding; conversely, liver-specific Irs2-knockout mice displayed insulin resistance during fasting but not after refeeding. We propose the concept of the existence of a dynamic relay between Irs1 and Irs2 in hepatic insulin signaling during fasting and feeding.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Irs1 is an insulin receptor substrate and when lost, leads to suppressed lipogenesis due to reduced insulin signaling20-22.”
From Positive selection of somatically mutated clones identifies adaptive pathways in metabolic liver disease (2023) · cites this paper as [21]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Complementary roles of IRS-1 and IRS-2 in the hepatic regulation of metabolism
Taniguchi, C. M., Ueki, K., & Kahn, C. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23187 · Cited by 286
Self-citationRetractedAkt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Insulin signalling and the regulation of glucose and lipid metabolism
Saltiel, A. R., & Kahn, C. R. (2001) · Nature · doi:10.1038/414799a · Cited by 5,326
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
Yamauchi, T., Kamon, J., Ito, Y., Tsuchida, A., Yokomizo, T., Kita, S., Sugiyama, T., Miyagishi, M., Hara, K., Tsunoda, M., et al. (2003) · Nature · doi:10.1038/nature01705 · Cited by 3,176
Self-citationCritical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760
Disruption of IRS-2 causes type 2 diabetes in mice
Withers, D. J., Gutierrez, J. S., Towery, H. H., Burks, D. J., Ren, J., Previs, S. F., Zhang, Y., Bernal, D., Pons, S., Shulman, G. I., et al. (1998) · Nature · doi:10.1038/36116 · Cited by 1,775
PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., Satoh, S., Nakano, R., Ishii, C., 杉山, 拓., et al. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80210-5 · Cited by 1,351
Self-citationMichael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296
Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene
Araki, E., Lipes, M. A., Patti, M.-E., Brüning, J. C., Haag III, B., Johnson, R. S., & Kahn, C. R. (1994) · Nature · doi:10.1038/372186a0 · Cited by 1,252
Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1
Tamemoto, H., Kadowaki, T., Tobe, K., Yagi, T., Sakura, H., Hayakawa, T., Terauchi, Y., Ueki, K., Kaburagi, Y., Satoh, S., et al. (1994) · Nature · doi:10.1038/372182a0 · Cited by 1,081
Self-citation
Cited by
Sorted by citations
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
“increases glycogen synthesis and the synthesis of fatty acids for storage and subsequent utilization by other tissues [82, 83].”
BackgroundBiochemical and cellular properties of insulin receptor signalling
Haeusler, R. A., McGraw, T. E., & Accili, D. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.89 · Cited by 739
Kammoun, H. L., Chabanon, H., Hainault, I., Luquet, S., Magnan, C., Koike, T., Ferré, P., & Foufelle, F. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37007 · Cited by 732
Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP‐1c
Ferré, P., & Foufelle, F. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01275.x · Cited by 737
FGF19 as a Postprandial, Insulin-Independent Activator of Hepatic Protein and Glycogen Synthesis
Kir, S., Beddow, S. A., Samuel, V. T., Miller, P., Previs, S. F., Suino-Powell, K., Xu, H. E., Shulman, G. I., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Science · doi:10.1126/science.1198363 · Cited by 637
Guo, S. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0327 · Cited by 648
Hepatic mTORC2 Activates Glycolysis and Lipogenesis through Akt, Glucokinase, and SREBP1c
Hagiwara, A., Cornu, M., Cybulski, N., Polak, P., Betz, C., Trapani, F., Terracciano, L., Heim, M. H., Rüegg, M. A., & Hall, M. N. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.015 · Cited by 585
The role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 571
Role of Insulin Resistance in MAFLD
Sakurai, Y., Kubota, N., Yamauchi, T., & Kadowaki, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22084156 · Cited by 448
Self-citationGut microbial carbohydrate metabolism contributes to insulin resistance
Takeuchi, T., Kubota, T., Nakanishi, Y., Tsugawa, H., Suda, W., Kwon, A. T.-J., Yazaki, J., Ikeda, K., Nemoto, S., Mochizuki, Y., et al. (2023) · Nature · doi:10.1038/s41586-023-06466-x · Cited by 467
Self-citationKubota, T., Kubota, N., Kumagai, H., Yamaguchi, S., Kozono, H., Takahashi, T., Inoue, M., Itoh, S., Takamoto, I., Sasako, T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.01.018 · Cited by 435
Self-citationPostreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis
Semple, R. K., Sleigh, A., Murgatroyd, P. R., Adams, C. A., Bluck, L. J. C., Jackson, S. J., Vottero, A., Kanabar, D. J., Charlton-Menys, V., Durrington, P. N., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37432 · Cited by 347
Foxo1 integrates insulin signaling with mitochondrial function in the liver
Cheng, Z., Guo, S., Copps, K., Dong, X., Kollipara, R., Rodgers, J. T., Depinho, R. A., Puigserver, P., & White, M. F. (2009) · Nature Medicine · doi:10.1038/nm.2049 · Cited by 321
Bo, T., Gao, L., Yao, Z., Shao, S., Wang, X., Proud, C. G., & Zhao, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.04.006 · Cited by 293
Akt2 Is Required for Hepatic Lipid Accumulation in Models of Insulin Resistance
Leavens, K. F., Easton, R., Shulman, G. I., Previs, S. F., & Birnbaum, M. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.004 · Cited by 289
Awazawa, M., Ueki, K., Inabe, K., Yamauchi, T., Kubota, N., Kaneko, K., Kobayashi, M., Iwane, A., Sasako, T., Okazaki, Y., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.02.010 · Cited by 277
Self-citationThe role of FOXO in the regulation of metabolism
Gross, D. N., Wan, M., & Birnbaum, M. J. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0034-5 · Cited by 244
Mitochondrial Dysfunction, Insulin Resistance, and Potential Genetic Implications
Sangwung, P., Petersen, K. F., Shulman, G. I., & Knowles, J. W. (2020) · Endocrinology · doi:10.1210/endocr/bqaa017 · Cited by 232
Insulin action at a molecular level – 100 years of progress
White, M. F., & Kahn, C. R. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101304 · Cited by 221
Fibroblast Growth Factor-19, a Novel Factor That Inhibits Hepatic Fatty Acid Synthesis
Bhatnagar, S., Damron, H. A., & Hillgartner, F. B. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m808818200 · Cited by 212
Lessons from Mouse Models of High-Fat Diet-Induced NAFLD
Nakamura, A., & Terauchi, Y. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141121240 · Cited by 196
Self-citationAleman, A., & Torres‐Alemán, I. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.07.008 · Cited by 192
Hepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
Zhang, K., Li, L., Qi, Y., Zhu, X., Gan, B., DePinho, R. A., Averitt, T., & Guo, S. (2011) · Endocrinology · doi:10.1210/en.2011-1527 · Cited by 179
Long, Y. C., Cheng, Z., Copps, K. D., & White, M. F. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00983-10 · Cited by 183
Hippo-mediated suppression of IRS2/AKT signaling prevents hepatic steatosis and liver cancer
Jeong, S., Kim, H.-B., Kim, M., Lee, J.-M., Lee, J. H., Kim, J., Kim, J. W., Park, W., Kim, S., Kim, J. B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci95802 · Cited by 176
Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences
Hijmans, B. S., Grefhorst, A., Oosterveer, M. H., & Groen, A. K. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.007 · Cited by 184
Kubota, T., Kubota, N., & Kadowaki, T. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.004 · Cited by 174
Self-citationInsulin signaling to hepatic lipid metabolism in health and disease
Leavens, K. F., & Birnbaum, M. J. (2011) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2011.562481 · Cited by 169
Guo, S., Copps, K. D., Dong, X. C., Park, S., Cheng, Z., Pocai, A., Rossetti, L., Sajan, M. P., Farese, R. V., & White, M. F. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00138-09 · Cited by 152
Taniguchi, C. M., Finger, E. C., Krieg, A. J., Wu, C., Diep, A. N., LaGory, E. L., Wei, K., McGinnis, L. M., Yuan, J., Kuo, C. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3294 · Cited by 150
Hardwick, J. P., Osei‐Hyiaman, D., Wiland, H. O., Abdelmegeed, M. A., & Song, B. (2009) · PPAR Research · doi:10.1155/2009/952734 · Cited by 148
Kubota, N., Kubota, T., Kajiwara, E., Iwamura, T., Kumagai, H., Watanabe, T., Inoue, M., Takamoto, I., Sasako, T., Kumagai, K., et al. (2016) · Nature Communications · doi:10.1038/ncomms12977 · Cited by 143
Self-citationObata, A., Kubota, N., Kubota, T., Iwamoto, M., Satō, H., Sakurai, Y., Takamoto, I., Katsuyama, H., Suzuki, Y., Fukazawa, M., et al. (2015) · Endocrinology · doi:10.1210/en.2015-1588 · Cited by 143
Self-citationInsulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 130
Roles of FGF19 in Liver MetabolismPreprint
Kır, S., Kliewer, S. A., & Mangelsdorf, D. J. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010710 · Cited by 128
Besse-Patin, A., Jeromson, S., Levesque-Damphousse, P., Secco, B., Laplante, M., & Estall, J. L. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1815150116 · Cited by 124
Postprandial hyperglycemia and postprandial hypertriglyceridemia in type 2 diabetes
Hiyoshi, T., Fujiwara, M., & Zemin, Y. (2018) · Journal of Biomedical Research · doi:10.7555/jbr.31.20160164 · Cited by 112
Selective insulin resistance with differential expressions of IRS-1 and IRS-2 in human NAFLD livers
Honma, M., Sawada, S., Ueno, Y., Murakami, K., Yamada, T., Gao, J., Kodama, S., Izumi, T., Takahashi, K., Tsukita, S., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0062-9 · Cited by 108
Oishi, K., Yamamoto, S., Itoh, N., Nakao, R., Yasumoto, Y., Tanaka, K., Kikuchi, Y., Fukudome, S.-I., Okita, K., & Takano‐Ishikawa, Y. (2014) · Journal of Nutrition · doi:10.3945/jn.114.202754 · Cited by 107
Inhibition of PTP1B Restores IRS1-Mediated Hepatic Insulin Signaling in IRS2-Deficient Mice
González‐Rodríguez, Á., Gutierrez, J. A. M., Sanz-Gonzalez, S. M., Ros, M., Burks, D. J., & Valverde, Á. M. (2009) · Diabetes · doi:10.2337/db09-0796 · Cited by 108
Tissue‐specific insulin signaling in the regulation of metabolism and aging
Zhang, J., & Liu, F. (2014) · IUBMB Life · doi:10.1002/iub.1293 · Cited by 105
A liver Hif-2α–Irs2 pathway sensitizes hepatic insulin signaling and is modulated by Vegf inhibition
Wei, K., Piecewicz, S., McGinnis, L. M., Taniguchi, C. M., Wiegand, S. J., Anderson, K., Chan, C. W. M., Mulligan, K. X., Kuo, D. C., Yuan, J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3295 · Cited by 102
Hepatic Sdf2l1 controls feeding-induced ER stress and regulates metabolism
Sasako, T., Ohsugi, M., Kubota, N., Itoh, S., Okazaki, Y., Terai, A., Kubota, T., Yamashita, S., Nakatsukasa, K., Kamura, T., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-08591-6 · Cited by 92
Self-citationZinc Finger Protein Zbtb20 Is Essential for Postnatal Survival and Glucose Homeostasis
Sutherland, A. P. R., Zhang, H., Zhang, Y., Michaud, M., Xie, Z., Patti, M., Grusby, M. J., & Zhang, W. J. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01667-08 · Cited by 92
Hoene, M., Lehmann, R., Hennige, A. M., Pohl, A. K., Häring, H. U., Schleicher, E. D., & Weigert, C. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2008.160275 · Cited by 94
Fukushima, A., Loh, K., Galić, S., Fam, B. C., Shields, B., Wiede, F., Tremblay, M. L., Watt, M. J., Andrikopoulos, S., & Tiganis, T. (2010) · Diabetes · doi:10.2337/db09-1365 · Cited by 94
Pajvani, U. B., & Accili, D. (2015) · Diabetologia · doi:10.1007/s00125-015-3722-5 · Cited by 92
Of rodents and men: Species-specific glucose regulation and type 2 diabetes research
Chandrasekera, P. C. (2014) · ALTEX · doi:10.14573/1309231 · Cited by 88
Takamoto, I., Kubota, N., Nakaya, K., Kumagai, K., Hashimoto, S., Kubota, T., Inoue, M., Kajiwara, E., Katsuyama, H., Obata, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3131-6 · Cited by 89
Self-citationTruong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“In line with this, liver-specific KO of INSR, dual IRS1/2, or AKT2 in mice exhibits both increased gluco-neogenesis and decreased lipogenesis, a phenotype referred to as ‘total IR’ [17,41,46-48].”
Gong, P., Xiao, X., Wang, S., Shi, F., Liu, N., Chen, X., Yang, W., Wang, L., & Chen, F. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114558 · Cited by 87
RetractedDual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney
Sasaki, M., Sasako, T., Kubota, N., Sakurai, Y., Takamoto, I., Kubota, T., Inagi, R., Seki, G., Goto, M., Ueki, K., et al. (2017) · Diabetes · doi:10.2337/db16-1602 · Cited by 79
Self-citationModulation of Insulin Sensitivity by Insulin-Degrading Enzyme
González-Casimiro, C. M., Merino, B., Casanueva-Álvarez, E., Postigo, T., Cámara-Torres, P., Fernández-Díaz, C. M., Leissring, M. A., Cózar‐Castellano, I., & Perdomo, G. (2021) · Biomedicines · doi:10.3390/biomedicines9010086 · Cited by 81
Dissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 82
From chronic overfeeding to hepatic injury: Role of endoplasmic reticulum stress and inflammation
Mollica, M. P., Lionetti, L., Putti, R., Cavaliere, G., Gaita, M., & Barletta, A. (2011) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2010.10.012 · Cited by 81
Clément, S., Peyrou, M., Sanchez-Pareja, A., Bourgoin, L., Ramadori, P., Suter, D. M., Vinciguerra, M., Guilloux, K., Pascarella, S., Rubbia‐Brandt, L., et al. (2011) · Hepatology · doi:10.1002/hep.24340 · Cited by 78
Kubota, T., Inoue, M., Kubota, N., Takamoto, I., Mineyama, T., Iwayama, K., Tokuyama, K., Moroi, M., Ueki, K., Yamauchi, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07358-9 · Cited by 80
Self-citationXu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 76
Wang, Z., Zhu, S., Jia, Y., Wang, Y., Kubota, N., Fujiwara, N., Gordillo, R., Lewis, C., Zhu, M., Sharma, T., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.014 · Cited by 72
Self-citationGeraldes, P., Yagi, K., Ohshiro, Y., He, Z., Maeno, Y., Hiraoka‐Yamamoto, J., Rask‐Madsen, C., Chung, S. W., Perrella, M. A., & King, G. L. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807036200 · Cited by 71
(2008) · doi:10.1016/j.cmet.2008.06.010 · Cited by 67
Li, Y., Tang, Y., Shi, S., Gao, S., Wang, Y., Xiao, D., Chen, T., He, Q. P., Zhang, J., & Lin, Y. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c11468 · Cited by 65
Okamoto, M. M., Anhê, G. F., Silva, R. S., Marques, M. F. D. S. F., Freitas, H. S., Mori, R. C. T., Melo, K. F. S., & Machado, U. F. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0105 · Cited by 67
Kawano, Y., Nakae, J., Watanabe, N., Fujisaka, S., Iskandar, K., Sekioka, R., Hayashi, Y., Tobe, K., Kasuga, M., Noda, T., et al. (2012) · Diabetes · doi:10.2337/db11-0770 · Cited by 63
Self-citationRabiee, A., Krüger, M., Ardenkjær-Skinnerup, J., Kahn, C. R., & Emanuelli, B. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.003 · Cited by 68
Sato, N., Takeda, S., Uchio‐Yamada, K., Ueda, H., Fujisawa, T., Rakugi, H., & Morishita, R. (2011) · Current Aging Science · doi:10.2174/1874609811104020118 · Cited by 61
Tao, R., Xiong, X., Harris, R. A., White, M. F., & Dong, X. C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071997 · Cited by 60
Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice
Tajima, K., Nakamura, A., Shirakawa, J., Togashi, Y., Orime, K., Sato, K., Inoue, H., Kaji, M., Sakamoto, E., Ito, Y., et al. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00133.2013 · Cited by 59
Self-citationAdipokines and Redox Signaling: Impact on Fatty Liver Disease
Parola, M., & Marra, F. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3848 · Cited by 60
Kobayashi, N., Ueki, K., Okazaki, Y., Iwane, A., Kubota, N., Ohsugi, M., Awazawa, M., Kobayashi, M., Sasako, T., Kaneko, K., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016430108 · Cited by 57
Self-citationSchisandrin B: A Double‐Edged Sword in Nonalcoholic Fatty Liver Disease
Leong, P. K., & Ko, K. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6171658 · Cited by 56
Erlandsson, M. C., Silfverswärd, S. T., Nadali, M., Turkkila, M., Svensson, M. N. D., Jonsson, I., Andersson, K., & Bokarewa, M. I. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.06.002 · Cited by 58
Cai, X., Fang, C., Hayashi, S., Hao, S., Zhao, M., Tsutsui, H., Nishiguchi, S., & Sheng, J. (2016) · Journal of Gastroenterology · doi:10.1007/s00535-015-1154-0 · Cited by 58
Current perspectives of insulin resistance and polycystic ovary syndrome
Pauli, J. M., Raja-Khan, N. T., Wu, X., & Legro, R. S. (2011) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03460.x · Cited by 55
Yang, X., Nath, A., Opperman, M. J., & Chan, C. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-06-0481 · Cited by 53
Accili, D. (2018) · Diabetes · doi:10.2337/dbi18-0025 · Cited by 52
Ashworth, W. B., Davies, N. A., & Bogle, I. D. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005105 · Cited by 50
Role of insulin receptor substrates in the progression of hepatocellular carcinoma
Sakurai, Y., Kubota, N., Takamoto, I., Obata, A., Iwamoto, M., Hayashi, T., Aihara, M., Kubota, T., Nishihara, H., & Kadowaki, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03299-3 · Cited by 51
Self-citationLiver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 51
Nakamura, A., Tajima, K., Zolzaya, K., Sato, K., Inoue, R., Yoneda, M., Fujita, K., Nozaki, Y., Kubota, K. C., Haga, H., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2703-1 · Cited by 48
Self-citationObrochta, K. M., Krois, C. R., Campos, B., & Napoli, J. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.609313 · Cited by 50
Marafie, S. K., ALSHAWAF, E. M. M., Abubaker, J. A., & Arefanian, H. (2019) · Biological Research · doi:10.1186/s40659-019-0253-4 · Cited by 48
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 53
Liew, C. W., Aßmann, A., Templin, A. T., Raum, J. C., Lipson, K. L., Rajan, S., Qiang, G., Hu, J., Kawamori, D., Lindberg, I., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323066111 · Cited by 45
Rametta, R., Mozzi, E., Dongiovanni, P., Motta, B. M., Milano, M., Roviaro, G., Fargion, S. R., & Valenti, L. V. C. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.181 · Cited by 44
High-fructose corn syrup-induced hepatic dysfunction in rats: improving effect of resveratrol
Sadı, G., Ergin, V., Yılmaz, G., Pektaş, M. B., Yıldırım, O. G., Menevşe, A., & Akar, F. (2014) · European Journal of Nutrition · doi:10.1007/s00394-014-0765-1 · Cited by 43
Central insulin-mediated regulation of hepatic glucose production [Review]
Inoue, H. (2016) · Endocrine Journal · doi:10.1507/endocrj.ej15-0540 · Cited by 43
Fritsche, L., Hoene, M., Lehmann, R., Ellingsgaard, H., Hennige, A. M., Pohl, A. K., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · Diabetologia · doi:10.1007/s00125-010-1754-4 · Cited by 41
Fritsche, L., Neukamm, S. S., Lehmann, R., Kremmer, E., Hennige, A. M., Hunder-Gugel, A., Schenk, M., Häring, H., Schleicher, E. D., & Weigert, C. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00409.2010 · Cited by 40
Knockout mouse models of insulin signaling: Relevance past and future
Bunner, A. E., Chandrasekera, P. C., & Barnard, N. D. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i2.146 · Cited by 44
Akar, F., Şumlu, E., Alçığır, M. E., Bostancı, A., & Sadı, G. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110287 · Cited by 40
Impaired PRMT1 activity in the liver and pancreas of type 2 diabetic Goto–Kakizaki rats
Iwasaki, H. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.05.007 · Cited by 39
Verwanger (2009) · International Journal of Oncology · doi:10.3892/ijo_00000407 · Cited by 40
Tian, Y., Liu, Y., Wang, S., Dong, Y., Su, T., Ma, H., & Zhang, Y. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.02.053 · Cited by 39
Houser, D. S., Crocker, D. E., Tift, M. S., & Champagne, C. D. (2012) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00101.2012 · Cited by 37
Dietary protein deprivation upregulates insulin signaling and inhibits gluconeogenesis in rat liver
Toyoshima, Y., Tokita, R., Ohne, Y., Hakuno, F., Noguchi, T., Minami, S., Kato, H., & Takahashi, S. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-10-0102 · Cited by 39
Kwok, A., Zvetkova, I., Virtue, S., Luijten, I. H. N., Huang‐Doran, I., Tomlinson, P. R., Bulger, D. A., West, J. A., Murfitt, S. A., Griffin, J. L., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101020 · Cited by 36
Enooku, K., Kondo, M., Fujiwara, N., Sasako, T., Shibahara, J., Kado, A., Okushin, K., Fujinaga, H., Tsutsumi, T., Nakagomi, R., et al. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1472-0 · Cited by 35
Self-citationThe Association of Acute Phase Proteins in Stress and Inflammation-Induced T2D
Speelman, T., Dale, L., Louw, A., & Verhoog, N. J. D. (2022) · Cells · doi:10.3390/cells11142163 · Cited by 38
MiR-126 Suppresses the Glucose-Stimulated Proliferation via IRS-2 in INS-1 β Cells
Hong, T., Wang, M., Zhang, M., Zhang, S., Wang, C., Yuan, W., Sun, T., He, L., & Hu, Q. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149954 · Cited by 35
Metadata
- Authors
- Kubota, N., Kubota, T., Itoh, S., Kumagai, H., Kozono, H., Takamoto, I., Mineyama, T., Ogata, H., Tokuyama, K., Ohsugi, M., Sasako, T., Moroi, M., Sugi, K., Kakuta, S., Iwakura, Y., Noda, T., Ohnishi, S., Nagai, R., Tobe, K., Terauchi, Y., Ueki, K., & Kadowaki, T.
- Affiliations
- National Institute of Health and Nutrition (JP)
- Toho University (JP)
- Kowa (Japan) (JP)
- The University of Tokyo (JP)
- University of Tsukuba (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- Japanese Foundation For Cancer Research (JP)
- University of Toyama (JP)
- Yokohama City University (JP)
- Corresponding author
- Kadowaki, Takashi
- ORCID
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2008-07
- Volume
- 8
- Issue
- 1
- Pages
- 49-64
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W1969750989
- Cited by
- 244
- References
- 37
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 15 · 2023: 11 · 2022: 6 · 2021: 18 · 2020: 9 · 2019: 8 · 2018: 17 · 2017: 10 · 2016: 10 · 2015: 7 · 2014: 15 · 2013: 24 · 2012: 15
- FWCI
- 8.77
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cell Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology (16209030, 18209033, 19591037)
- Core Research for Evolutional Science and Technology
- Japan Science and Technology Corporation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- IRS-1, insulin receptor substrate 2, hepatic insulin signaling, glucose homeostasis, fasting, refeeding, insulin resistance, liver-specific knockout mice
- MeSH terms
- Animals, Eating, Fasting, Glucose, Homeostasis, Insulin, Insulin Resistance, Liver, Phosphoproteins, Signal Transduction, Phosphatidylinositol 3-Kinases, Intracellular Signaling Peptides and Proteins, Adaptor Proteins, Signal Transducing, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review